These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29722943)

  • 1. [Testosterone Undecanoate Pills improves insulin resistance in type-2 diabetes men with hypogonadism].
    DI HJ; Fan YF; Zhang HF; Liu KM; Liu C
    Zhonghua Nan Ke Xue; 2017 Jun; 23(6):517-521. PubMed ID: 29722943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hypogonadism with testosterone in patients with type 2 diabetes mellitus.
    Gopal RA; Bothra N; Acharya SV; Ganesh HK; Bandgar TR; Menon PS; Shah NS
    Endocr Pract; 2010; 16(4):570-6. PubMed ID: 20150021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
    Giagulli VA; Carbone MD; Ramunni MI; Licchelli B; De Pergola G; Sabbà C; Guastamacchia E; Triggiani V
    Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
    Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P;
    J Sex Med; 2014 Mar; 11(3):840-56. PubMed ID: 24308723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    BJU Int; 2016 Nov; 118(5):804-813. PubMed ID: 27124889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
    Yassin DJ; Doros G; Hammerer PG; Yassin AA
    J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waist circumference is superior to weight and BMI in predicting sexual symptoms, voiding symptoms and psychosomatic symptoms in men with hypogonadism and erectile dysfunction.
    Yassin AA; Nettleship JE; Salman M; Almehmadi Y
    Andrologia; 2017 May; 49(4):. PubMed ID: 27400881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: an observational study.
    Haider A; Saad F; Doros G; Gooren L
    Obes Res Clin Pract; 2014; 8(4):e339-49. PubMed ID: 25091355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study.
    Aversa A; Bruzziches R; Francomano D; Rosano G; Isidori AM; Lenzi A; Spera G
    J Sex Med; 2010 Oct; 7(10):3495-503. PubMed ID: 20646185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation Between Testosterone and Metabolic Index in Male Patients with Type 2 Diabetes Mellitus].
    Cao W; Zheng RD; Fan YF; Liu C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):235-238. PubMed ID: 29737067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral Testosterone Undecanoate Capsules combined with Qilin Pills for late-onset hypogonadism in males].
    Mao JB; Chen XG; Gui DW; Peng W; Zheng J
    Zhonghua Nan Ke Xue; 2017 May; 23(5):455-458. PubMed ID: 29717839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone therapy reduces insulin resistance in men with adult-onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open-label phase.
    Tishova Y; Kalinchenko S; Mskhalaya G; Hackett G; Livingston M; König C; Strange R; Zitzmann M; Mann A; Maarouf A; Ramachandran S
    Diabetes Obes Metab; 2024 Jun; 26(6):2147-2157. PubMed ID: 38433502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints.
    Permpongkosol S; Tantirangsee N; Ratana-olarn K
    J Sex Med; 2010 Nov; 7(11):3765-74. PubMed ID: 20807330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of testosterone replacement therapy on insulin sensitivity and body composition in congenital hypogonadism: A prospective longitudinal follow-up study.
    Reddy KC; Yadav SB
    J Postgrad Med; 2021; 67(2):67-74. PubMed ID: 33942770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.
    Kapoor D; Goodwin E; Channer KS; Jones TH
    Eur J Endocrinol; 2006 Jun; 154(6):899-906. PubMed ID: 16728551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone therapy has positive effects on anthropometric measures, metabolic syndrome components (obesity, lipid profile, Diabetes Mellitus control), blood indices, liver enzymes, and prostate health indicators in elderly hypogonadal men.
    Canguven O; Talib RA; El Ansari W; Yassin DJ; Salman M; Al-Ansari A
    Andrologia; 2017 Dec; 49(10):. PubMed ID: 28295504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study.
    Haider KS; Haider A; Saad F; Doros G; Hanefeld M; Dhindsa S; Dandona P; Traish A
    Diabetes Obes Metab; 2020 Nov; 22(11):2055-2068. PubMed ID: 32558149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of testosterone treatment on glucose metabolism in men with type 2 diabetes: a randomized controlled trial.
    Gianatti EJ; Dupuis P; Hoermann R; Strauss BJ; Wentworth JM; Zajac JD; Grossmann M
    Diabetes Care; 2014 Aug; 37(8):2098-107. PubMed ID: 24804695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Testosterone Therapy Improves Urinary and Sexual Function, and Quality of Life in Men with Hypogonadism: Results from a Propensity Matched Subgroup of a Controlled Registry Study.
    Haider KS; Haider A; Doros G; Traish A
    J Urol; 2018 Jan; 199(1):257-265. PubMed ID: 28728990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.